Zilovertamab
Product Specifications
UNSPSC Description
Zilovertamab (UC-961) is a humanised monoclonal antibody against ROR1 that blocks Wnt5a-induced ROR1 signalling[1].
Target Antigen
ROR
Type
Inhibitory Antibodies
Related Pathways
Metabolic Enzyme/Protease;Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zilovertamab.html
Purity
98.21
Solubility
10 mM in DMSO
Smiles
[Zilovertamab]
References & Citations
[1]Liu D, et, al. The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells. Pharmaceutics. 2022 Apr 11;14(4):837.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99201/Zilovertamab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99201/Zilovertamab-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![HLA-DRA Mouse Monoclonal Antibody [Clone ID: IPO-10]](https://cdn.genprice.uk/products/937/68dd189e061270361e8fd32c/imageurl/am32359pu-t.webp)
MBS1420978-01 0.02 mg (E-Coli)
Recombinant Salmonella typhi NADH-quinone oxidoreductase subunit I (nuoI)
Ask
View Details 
MBS1420978-02 0.1 mg (E-Coli)
Recombinant Salmonella typhi NADH-quinone oxidoreductase subunit I (nuoI)
Ask
View Details 
MBS1420978-03 0.02 mg (Yeast)
Recombinant Salmonella typhi NADH-quinone oxidoreductase subunit I (nuoI)
Ask
View Details MBS1420978-04 0.1 mg (Yeast)
Recombinant Salmonella typhi NADH-quinone oxidoreductase subunit I (nuoI)
Ask
View Details MBS1420978-05 0.02 mg (Baculovirus)
Recombinant Salmonella typhi NADH-quinone oxidoreductase subunit I (nuoI)
Ask
View Details